Hong Kong-listed Shandong Luoxin Pharmaceutical Group’s Privatization Offer

Kirkland & Ellis is advising Ally Bridge Group, as a joint offeror with a consortium established by an affiliate of the target company’s controlling shareholder and…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini

This content is for Standard 1 Year members only.
Login Join Now